Entero Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Entero Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q1 2024.
  • Entero Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 1.76M shares, a 1445% increase year-over-year.
  • Entero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 336K shares, a 837% increase from 2022.
  • Entero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 35.9K shares, a 15.5% decline from 2021.
  • Entero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 42.5K shares, a 98.5% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 1.76M +1.65M +1445% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 336K +300K +837% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 7.57M +7.34M +3207% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.27M +2.17M +2087% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 114K +40K +54.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 35.9K -6.59K -15.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 229K -82.6K -26.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 104K -7.71M -98.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 74K -5.46M -98.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 42.5K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 311K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 7.81M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 5.53M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.